Condition
Lower Gastrointestinal Bleeding
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Not Yet Recruiting2
Enrolling By Invitation1
Completed1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07073300Not Yet RecruitingPrimary
Endoscopic Findings in Patients Presented With Lower GIT Bleeding in Assiut University Hospitals, a Single-centre Study
NCT06985277Not ApplicableEnrolling By InvitationPrimary
Urgent Panendoscopy in Patients Presenting With Hematochezia
NCT06939907Not ApplicableNot Yet RecruitingPrimary
Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract
NCT03935360CompletedPrimary
Oakland-Jairath Score Validation
NCT04729946Not ApplicableTerminatedPrimary
Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System
NCT03464513Not ApplicableUnknownPrimary
MSCT Angiography in Bleeding
Showing all 6 trials